We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Udg Healthcare Public Limited Company | LSE:UDG | London | Ordinary Share | IE0033024807 | ORD EUR0.05 (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1,079.00 | 1,078.00 | 1,079.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMUDG
RNS Number : 5436Y
United Drug PLC
01 March 2012
Notification of Transactions of (1) Persons Discharging Managerial Responsibility and (2) Persons closely associated with Persons Discharging Managerial Responsibility
This form is intended for use by an issuer making a notification required by Rules 7.2 and 7.3 of the Central Bank of Ireland's Market Abuse Rules in relation to a person falling within either of the above categories of individual. These categories are defined in Regulation 12 (8) of the Market Abuse (Directive 2003/6/EC) Regulations 2005 and are detailed as part of this form.
All relevant boxes should be completed in block capital letters.
Name of the Issuer Name of person discharging managerial responsibilities 1 UNITED DRUG PLC 2 MR. HUGH FRIEL 3 State whether notification 4 Indicate whether the notification relates to a person closely is in respect of a holding of associated with a person the person referred to in 2 or discharging managerial responsibilities 3 above or in respect of a non-beneficial named in 2 and identify the interest connected person N/A RELATES TO PERSON NAMED IN 2 ----------------------------------------- --- ------------------------------------------- Description of shares or derivatives or other financial Name of registered shareholder(s) instruments linked to them and, if more than one, number of shares or derivatives or other financial instruments linked to them, held by each shareholder ORDINARY SHARES OF EUR0.05 5 EACH 6 MR. HUGH FRIEL ----------------------------------------- --- ------------------------------------------- State the nature of the transaction Number of shares, derivatives PARTICIPATION IN DIVIDEND or other financial instruments REINVESTMENT PLAN RELATING linked to them acquired TO FINAL DIVIDEND FOR YEAR 7 END 30 SEPTEMBER 2011 8 466 ----------------------------------------- --- ------------------------------------------- Price per share or derivative Number of shares, derivatives or other financial instrument or other financial instruments linked to them or value of transaction linked to them disposed of 9 N/A 10 EUR2.198226 ----------------------------------------- --- ------------------------------------------- Date and place of transaction Date issuer informed of transaction 20 FEBRUARY - 1 MARCH 2012 11 DUBLIN, LONDON 12 1 MARCH 2012 ----------------------------------------- --- ------------------------------------------- Name of contact and telephone number for queries Any additional information KAREN GEOGHEGAN 13 N/A 14 + 353 1 463 7720 ----------------------------------------- --- ------------------------------------------- Name and signature of duly designated officer of issuer responsible for making notification KAREN GEOGHEGAN_____________________________ Date of notification 1 MARCH 2012___________________ --- -------------------------------------------------------------------------------------------
The following information is required under the Irish Stock Exchange's Listing Rule 6.10. An issuer is not required to submit the following information to the Central Bank of Ireland.
15 Description of class of 16 Percentage of issued class acquired share (treasury shares of that class should not be taken into account when calculating percentage) ORDINARY SHARES 0.00019% Percentage of issued class Total holding following notification disposed (treasury shares and total percentage holding following of that class should not notification (any treasury shares be taken into account when should not be taken into account calculating percentage) when calculating percentage) 17 N/A 18 21,241 (0.0088%) ---------------------------- --- --------------------------------------------
If a person discharging managerial responsibilities has been granted options by the issuer, please complete the following boxes:
Date of grant Period during which or date on which it can be exercised 19 N/A 20 N/A Description of shares involved (class Total amount paid (if any) and number) for grant of the option 21 N/A 22 N/A --------------------------------- --- ----------------------------------------- 23 Exercise price (if fixed 24 Total number of shares over which at time of grant) or indication options are held following notification that the price is to be fixed at the time of exercise N/A N/A --------------------------------- --- -----------------------------------------
Notification of Transactions of (1) Persons Discharging Managerial Responsibility and (2) Persons closely associated with Persons Discharging Managerial Responsibility
This form is intended for use by an issuer making a notification required by Rules 7.2 and 7.3 of the Central Bank of Ireland's Market Abuse Rules in relation to a person falling within either of the above categories of individual. These categories are defined in Regulation 12 (8) of the Market Abuse (Directive 2003/6/EC) Regulations 2005 and are detailed as part of this form.
All relevant boxes should be completed in block capital letters.
Name of the Issuer Name of person discharging managerial responsibilities 1 UNITED DRUG PLC 2 MR. LIAM LOGUE 3 State whether notification 4 Indicate whether the notification relates to a person closely is in respect of a holding of associated with a person the person referred to in 2 or discharging managerial responsibilities 3 above or in respect of a non-beneficial named in 2 and identify the interest connected person N/A RELATES TO PERSON NAMED IN 2 ----------------------------------------- --- ------------------------------------------- Description of shares or derivatives or other financial Name of registered shareholder(s) instruments linked to them and, if more than one, number of shares or derivatives or other financial instruments linked to them, held by each shareholder ORDINARY SHARES OF EUR0.05 5 EACH 6 MR. LIAM LOGUE ----------------------------------------- --- ------------------------------------------- State the nature of the transaction Number of shares, derivatives PARTICIPATION IN DIVIDEND or other financial instruments REINVESTMENT PLAN RELATING linked to them acquired TO FINAL DIVIDEND FOR YEAR 7 END 30 SEPTEMBER 2011 8 327 ----------------------------------------- --- ------------------------------------------- Price per share or derivative Number of shares, derivatives or other financial instrument or other financial instruments linked to them or value of transaction linked to them disposed of 9 N/A 10 EUR2.198226 ----------------------------------------- --- ------------------------------------------- Date and place of transaction Date issuer informed of transaction 20 FEBRUARY - 1 MARCH 2012 11 DUBLIN, LONDON 12 1 MARCH 2012 ----------------------------------------- --- ------------------------------------------- Name of contact and telephone number for queries Any additional information KAREN GEOGHEGAN 13 N/A 14 + 353 1 463 7720 ----------------------------------------- --- ------------------------------------------- Name and signature of duly designated officer of issuer responsible for making notification KAREN GEOGHEGAN_____________________________ Date of notification 1 MARCH 2012___________________ --- -------------------------------------------------------------------------------------------
The following information is required under the Irish Stock Exchange's Listing Rule 6.10. An issuer is not required to submit the following information to the Central Bank of Ireland.
15 Description of class of 16 Percentage of issued class acquired share (treasury shares of that class should not be taken into account when calculating percentage) ORDINARY SHARES 0.00013% Percentage of issued class Total holding following notification disposed (treasury shares and total percentage holding following of that class should not notification (any treasury shares be taken into account when should not be taken into account calculating percentage) when calculating percentage) 17 N/A 18 19,814 (0.0083%) ---------------------------- --- --------------------------------------------
If a person discharging managerial responsibilities has been granted options by the issuer, please complete the following boxes:
Date of grant Period during which or date on which it can be exercised 19 N/A 20 N/A Description of shares involved (class Total amount paid (if any) and number) for grant of the option 21 N/A 22 N/A --------------------------------- --- ----------------------------------------- 23 Exercise price (if fixed 24 Total number of shares over which at time of grant) or indication options are held following notification that the price is to be fixed at the time of exercise N/A N/A --------------------------------- --- -----------------------------------------
Notification of Transactions of (1) Persons Discharging Managerial Responsibility and (2) Persons closely associated with Persons Discharging Managerial Responsibility
This form is intended for use by an issuer making a notification required by Rules 7.2 and 7.3 of the Central Bank of Ireland's Market Abuse Rules in relation to a person falling within either of the above categories of individual. These categories are defined in Regulation 12 (8) of the Market Abuse (Directive 2003/6/EC) Regulations 2005 and are detailed as part of this form.
All relevant boxes should be completed in block capital letters.
Name of the Issuer Name of person discharging managerial responsibilities 1 UNITED DRUG PLC 2 MR. BARRY MCGRANE 3 State whether notification 4 Indicate whether the notification relates to a person closely is in respect of a holding of associated with a person the person referred to in 2 or discharging managerial responsibilities 3 above or in respect of a non-beneficial named in 2 and identify the interest connected person N/A RELATES TO PERSON NAMED IN 2 ----------------------------------------- --- ------------------------------------------- Description of shares or derivatives or other financial Name of registered shareholder(s) instruments linked to them and, if more than one, number of shares or derivatives or other financial instruments linked to them, held by each shareholder ORDINARY SHARES OF EUR0.05 5 EACH 6 MR. BARRY MCGRANE ----------------------------------------- --- ------------------------------------------- State the nature of the transaction Number of shares, derivatives PARTICIPATION IN DIVIDEND or other financial instruments REINVESTMENT PLAN RELATING linked to them acquired TO FINAL DIVIDEND FOR YEAR 7 END 30 SEPTEMBER 2011 8 16,789 ----------------------------------------- --- ------------------------------------------- Price per share or derivative Number of shares, derivatives or other financial instrument or other financial instruments linked to them or value of transaction linked to them disposed of 9 N/A 10 EUR2.198226 ----------------------------------------- --- ------------------------------------------- Date and place of transaction Date issuer informed of transaction 20 FEBRUARY - 1 MARCH 2012 11 DUBLIN, LONDON 12 1 MARCH 2012 ----------------------------------------- --- ------------------------------------------- Name of contact and telephone number for queries Any additional information KAREN GEOGHEGAN 13 N/A 14 + 353 1 463 7720 ----------------------------------------- --- ------------------------------------------- Name and signature of duly designated officer of issuer responsible for making notification KAREN GEOGHEGAN_____________________________ Date of notification 1 MARCH 2012___________________ --- -------------------------------------------------------------------------------------------
The following information is required under the Irish Stock Exchange's Listing Rule 6.10.
An issuer is not required to submit the following information to the Central Bank of Ireland.
15 Description of class of 16 Percentage of issued class acquired share (treasury shares of that class should not be taken into account when calculating percentage) ORDINARY SHARES 0.007% Percentage of issued class Total holding following notification disposed (treasury shares and total percentage holding following of that class should not notification (any treasury shares be taken into account when should not be taken into account calculating percentage) when calculating percentage) 17 N/A 18 787,380 (0.32%) ---------------------------- --- --------------------------------------------
If a person discharging managerial responsibilities has been granted options by the issuer, please complete the following boxes:
Date of grant Period during which or date on which it can be exercised 19 N/A 20 N/A Description of shares involved (class Total amount paid (if any) and number) for grant of the option 21 N/A 22 N/A --------------------------------- --- ----------------------------------------- 23 Exercise price (if fixed 24 Total number of shares over which at time of grant) or indication options are held following notification that the price is to be fixed at the time of exercise N/A N/A --------------------------------- --- -----------------------------------------
This announcement has been issued through the Companies Announcement Service of
The Irish Stock Exchange.
This information is provided by RNS
The company news service from the London Stock Exchange
END
ISEUAOBRUAAORAR
1 Year Udg Healthcare Public Chart |
1 Month Udg Healthcare Public Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions